These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24685687)

  • 1. Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Takahashi H; Kadowaki S; Narumi T; Honda Y; Wanezaki M; Sasaki S; Tamura H; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    J Cardiol; 2014 Nov; 64(5):353-9. PubMed ID: 24685687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Shishido T; Takahashi H; Funayama A; Narumi T; Kadowaki S; Hasegawa H; Honda S; Netsu S; Ishino M; Arimoto T; Miyashita T; Miyamoto T; Konta T; Kubota I
    Circ Heart Fail; 2013 Jul; 6(4):662-8. PubMed ID: 23674363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Takahashi H; Funayama A; Kinoshita D; Yokoyama M; Takahashi T; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Clin Res Cardiol; 2016 Feb; 105(2):162-71. PubMed ID: 26220048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease.
    Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
    ESC Heart Fail; 2023 Aug; 10(4):2458-2468. PubMed ID: 37264723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
    Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
    Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
    Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise.
    Sugama K; Suzuki K; Yoshitani K; Shiraishi K; Miura S; Yoshioka H; Mori Y; Kometani T
    Exerc Immunol Rev; 2015; 21():130-42. PubMed ID: 25826051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Watanabe T; Nitobe J; Miyashita T; Takahashi H; Koyama Y; Kubota I
    J Cardiol; 2006 May; 47(5):219-28. PubMed ID: 16764328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide is upregulated and associated with mortality in patients with chronic heart failure.
    Yu J; Pan W; Shi R; Yang T; Li Y; Yu G; Bai Y; Schuchman EH; He X; Zhang G
    Can J Cardiol; 2015 Mar; 31(3):357-63. PubMed ID: 25746025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion.
    Tanaka T; Nishiyama Y; Okada K; Hirota K; Matsui M; Yodoi J; Hiai H; Toyokuni S
    Lab Invest; 1997 Aug; 77(2):145-55. PubMed ID: 9274857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
    Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
    Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
    Xue C; Feng Y; Wo J; Li Y
    N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular damage and worsening renal function in chronic heart failure.
    Damman K; Masson S; Hillege HL; Voors AA; van Veldhuisen DJ; Rossignol P; Proietti G; Barbuzzi S; Nicolosi GL; Tavazzi L; Maggioni AP; Latini R
    JACC Heart Fail; 2013 Oct; 1(5):417-24. PubMed ID: 24621973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.